Kurt Von Emster insider trades: CymaBay Therapeutics (CBAY) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kurt reports to the SEC
and 2 more companies
Open-market buys and sales
56 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 29, 2023 | CBAY | ↓ Sell | 15,921 | $15.68 | $250K | Direct | Sep 29, 2023 (0d) |
| Apr 13, 2023 | JSPR | ↓ Sell | 9,075 | $1.49 | $14K | Direct | Apr 14, 2023 (1d) |
| May 18, 2021 | VERA | ↑ Buy | 772,727 | $11.00 | $8.5M | Indirect | May 18, 2021 (0d) |
| May 17, 2021 | VERA | ↑ Buy | 17,828 | $12.04 | $215K | Direct | May 18, 2021 (1d) |
| Jun 16, 2020 | PCVX | ↑ Buy | 12,500 | $16.00 | $200K | Indirect | Jun 18, 2020 (2d) |
| Dec 18, 2018 | CRSP | ↓ Sell | 72,934 | $29.85 | $2.2M | Indirect | Dec 19, 2018 (1d) |
| Dec 18, 2018 | CBAY | ↓ Sell | 142,381 | $7.89 | $1.1M | Indirect | Dec 19, 2018 (1d) |
| Jun 5, 2018 | CBAY | ↓ Sell | 920 | $12.51 | $12K | By the Konrad Hans von Emster III and El | Jun 7, 2018 (2d) |
| Jun 5, 2018 | CRSP | ↓ Sell | 920 | $12.51 | $12K | By the Konrad Hans von Emster III and El | Jun 7, 2018 (2d) |
| May 14, 2018 | CRSP | ↓ Sell | 650,000 | $54.39 | $35.4M | Indirect | May 15, 2018 (1d) |
| Mar 5, 2018 | CBAY | ↓ Sell | 13,353 | $15.51 | $207K | Indirect | Mar 7, 2018 (2d) |
| Feb 15, 2018 | CBAY | ↓ Sell | 68,712 | $14.49 | $996K | Indirect | Feb 20, 2018 (5d) |
| Feb 14, 2018 | CBAY | ↓ Sell | 218,057 | $15.89 | $3.5M | Indirect | Feb 15, 2018 (1d) |
| Feb 7, 2018 | CBAY | ↓ Sell | 40,763 | $12.35 | $503K | Indirect | Feb 9, 2018 (2d) |
| Feb 5, 2018 | CBAY | ↓ Sell | 18,831 | $12.14 | $229K | Indirect | Feb 7, 2018 (2d) |
| Feb 2, 2018 | CBAY | ↓ Sell | 90,098 | $12.15 | $1.1M | Indirect | Feb 5, 2018 (3d) |
| Jan 31, 2018 | CBAY | ↓ Sell | 97,639 | $12.22 | $1.2M | Indirect | Feb 1, 2018 (1d) |
| Jan 25, 2018 | CBAY | ↓ Sell | 39,438 | $12.18 | $480K | Indirect | Jan 26, 2018 (1d) |
| Jan 22, 2018 | CBAY | ↓ Sell | 138,253 | $10.40 | $1.4M | Indirect | Jan 24, 2018 (2d) |
| Jan 19, 2018 | CBAY | ↓ Sell | 144,216 | $10.25 | $1.5M | Indirect | Jan 22, 2018 (3d) |
| Jan 5, 2018 | CRSP | ↑ Buy | 65,934 | $22.75 | $1.5M | Indirect | Jan 11, 2018 (6d) |
| Jan 5, 2018 | CRSP | ↓ Sell | 92,337 | $26.96 | $2.5M | Indirect | Jan 9, 2018 (4d) |
| Jan 5, 2018 | CBAY | ↓ Sell | 4,300 | $10.21 | $44K | Indirect | Jan 9, 2018 (4d) |
| Jan 2, 2018 | CRSP | ↓ Sell | 37,754 | $26.76 | $1.0M | Indirect | Jan 4, 2018 (2d) |
| Dec 22, 2017 | CBAY | ↓ Sell | 173,192 | $9.41 | $1.6M | Indirect | Dec 27, 2017 (5d) |
| Nov 10, 2017 | CBAY | ↓ Sell | 50,048 | $9.26 | $463K | Indirect | Nov 14, 2017 (4d) |
| Nov 1, 2017 | CBAY | ↓ Sell | 4,320 | $9.25 | $40K | Indirect | Nov 3, 2017 (2d) |
| Oct 31, 2017 | CBAY | ↓ Sell | 59,209 | $9.27 | $549K | Indirect | Nov 1, 2017 (1d) |
| Oct 3, 2017 | CBAY | ↓ Sell | 108,876 | $7.85 | $855K | Indirect | Oct 4, 2017 (1d) |
| Sep 29, 2017 | CBAY | ↓ Sell | 211,124 | $8.09 | $1.7M | Indirect | Oct 2, 2017 (3d) |
| Aug 28, 2017 | CRSP | ↓ Sell | 88,011 | $19.79 | $1.7M | Indirect | Aug 30, 2017 (2d) |
| Aug 25, 2017 | CRSP | ↓ Sell | 22,781 | $19.42 | $442K | Indirect | Aug 28, 2017 (3d) |
| Aug 23, 2017 | CRSP | ↓ Sell | 17,989 | $18.53 | $333K | Indirect | Aug 24, 2017 (1d) |
| Aug 21, 2017 | CRSP | ↓ Sell | 3,150 | $18.52 | $58K | Indirect | Aug 22, 2017 (1d) |
| Aug 17, 2017 | CRSP | ↓ Sell | 34,141 | $19.06 | $651K | Indirect | Aug 18, 2017 (1d) |
| Aug 15, 2017 | CRSP | ↓ Sell | 55,569 | $19.59 | $1.1M | Indirect | Aug 16, 2017 (1d) |
| Aug 8, 2017 | CRSP | ↓ Sell | 35,473 | $18.63 | $661K | Indirect | Aug 9, 2017 (1d) |
| Aug 4, 2017 | CRSP | ↓ Sell | 50,477 | $17.81 | $899K | Indirect | Aug 7, 2017 (3d) |
| Aug 1, 2017 | CRSP | ↓ Sell | 5,512 | $17.51 | $96K | Indirect | Aug 2, 2017 (1d) |
| Jul 28, 2017 | CRSP | ↓ Sell | 41,312 | $17.63 | $728K | Indirect | Jul 31, 2017 (3d) |
| Jul 26, 2017 | CRSP | ↓ Sell | 32,930 | $17.60 | $580K | Indirect | Jul 27, 2017 (1d) |
| Jul 19, 2017 | CBAY | ↑ Buy | 153,846 | $6.50 | $1000K | Indirect | Feb 12, 2018 (208d) |
| Jul 14, 2017 | CRSP | ↓ Sell | 69,859 | $16.84 | $1.2M | Indirect | Jul 17, 2017 (3d) |
| Jul 12, 2017 | CRSP | ↓ Sell | 31,992 | $16.56 | $530K | Indirect | Jul 13, 2017 (1d) |
| Jul 5, 2017 | CRSP | ↓ Sell | 4,254 | $16.26 | $69K | Indirect | Jul 7, 2017 (2d) |
| Jun 29, 2017 | CRSP | ↓ Sell | 43,202 | $16.90 | $730K | Indirect | Jun 30, 2017 (1d) |
| Jun 27, 2017 | CRSP | ↓ Sell | 81,435 | $17.08 | $1.4M | Indirect | Jun 28, 2017 (1d) |
| Jun 23, 2017 | CRSP | ↓ Sell | 32,368 | $16.23 | $525K | Indirect | Jun 26, 2017 (3d) |
| Oct 24, 2016 | CRSP | ↑ Buy | 56,000 | $14.00 | $784K | Indirect | Feb 10, 2017 (109d) |
| Sep 5, 2012 | SOMX | ↓ Sell | 1,367 | $0.29 | $396 | By Trust | Sep 6, 2012 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Kurt Von Emster's insider trades
Kurt Von Emster is an insider at CymaBay Therapeutics (CBAY). Since Dec 20, 2005, Kurt has reported 7 open-market purchases worth $14.2M and 49 sales worth $72.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (40 filings), shares returned to the company (4 filings), conversions (4 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CBAY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.